Studies detail molecular pathway that impacts pancreatic cancer progression and response to treatment

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

University of Michigan Health Rogel Cancer Center received a $50 million gift from Richard and Susan Rogel for pancreatic cancer research and care.

November 08, 2024

Vol.50 No.42

Clinical Roundup

Survey shows dangerous knowledge gaps in pancreatic cancer

While pancreatic cancer rates are rising in people under age 50, a new survey conducted by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute shows that most people continue to believe that pancreatic disease affects only elderly people—and that there is nothing they can do to...

November 08, 2024

Vol.50 No.42

Regulatory News

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

More than a month has passed since Hurricane Helene took out Baxter North Cove plant, which manufactured 1.5 million IV fluid bags per day, supplying 60% of the intravenous solutions nationwide.

November 01, 2024

Vol.50 No.41

By Claire Marie Porter

In Brief

SU2C announces grants supporting research in six cancer types

Stand Up To Cancer announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, pancreatic, breast, rectal, and gastro-esophageal cancers, as well as research focused on how the microbiome communicates with the immune system.

October 18, 2024

Vol.50 No.39

In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on schedule
Helene knocks out Baxter facility, creating shortage of IV fluids

Hurricane Milton via satellite on Wednesday. Source: NOAA/NESDISSTAR GOES-EastMilton—the second hurricane in as many weeks—ripped through America’s southeast, causing severe flooding, washing away bridges, knocking out power and water supply.

October 11, 2024

Vol.50 No.38

By Claire Marie Porter

Clinical Roundup

UT Health San Antonio creates pancreatic cancer organoid

A study by scientists at the University of Texas Health Science Center at San Antonio provides one of the first models to study the progression of normal human pancreatic cells toward tumor cells.

October 04, 2024

Vol.50 No.37

Studies detail molecular pathway that impacts pancreatic cancer progression and response to treatment

YOU MAY BE INTERESTED IN

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

Survey shows dangerous knowledge gaps in pancreatic cancer

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

SU2C announces grants supporting research in six cancer types

In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on schedule
Helene knocks out Baxter facility, creating shortage of IV fluids

UT Health San Antonio creates pancreatic cancer organoid

Renew today!

Subscriber content

Login

Studies detail molecular pathway that impacts pancreatic cancer progression and response to treatment

YOU MAY BE INTERESTED IN

UMich Rogel Cancer Center receives $50M for pancreatic cancer care, research

Survey shows dangerous knowledge gaps in pancreatic cancer

FDA extends shelf-life for IV fluids in shortage after Hurricane Helene

SU2C announces grants supporting research in six cancer types

In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on scheduleHelene knocks out Baxter facility, creating shortage of IV fluids

UT Health San Antonio creates pancreatic cancer organoid

Login

In the aftermath of Helene and Milton, oncologists resort to airlifts to keep treatments on schedule
Helene knocks out Baxter facility, creating shortage of IV fluids